1
Participants
Start Date
November 30, 2016
Primary Completion Date
April 5, 2019
Study Completion Date
July 7, 2020
TubeClear® intervention
The TubeClear® device is deemed by the Food and Drug Administration (FDA) to be non-significant risk (NSR) for use in this study. It is a control box and a single use clearing stem used to resolve the clog in an enteral access device within five minutes following the intervention.
Children's Hospital of Philadelphia, Philadelphia
Collaborators (1)
Actuated Medical, Inc.
INDUSTRY
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Children's Hospital of Philadelphia
OTHER